Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03639779 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Intralesional Sodium Thiosulfate Versus Intralesional Saline for Dystrophic and Idiopathic Calcinosis Cutis
A Phase 4 study, sponsored by University of Central Florida.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT03639779 is a Phase 4 study that was terminated before completion, run by University of Central Florida. The registered enrollment target is 5 participants.
The verdict
NCT03639779, a Phase 4 study, was terminated before completion, sponsored by University of Central Florida.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of our research is to compare the effectiveness of 125mg/50ml sodium thiosulfate (STS) solution to normal saline (0.9% sodium chloride) when injected intralesionally for the treatment of calcinosis cutis. Our specific aim is to assess the response of dystrophic and idiopathic calcinosis cutis to the injections of sodium thiosulfate in our patients.
Interventions
- OTHER Saline Solution
- DRUG Sodium Thiosulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-11-02 |
| Est. Completion | 2019-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03639779
The ClinicalTrials.gov registry entry for NCT03639779 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline Solution is the first listed.
NCT03639779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03639779 about?
NCT03639779 is a clinical study titled "Efficacy of Intralesional Sodium Thiosulfate Versus Intralesional Saline for Dystrophic and Idiopathic Calcinosis Cutis". The purpose of our research is to compare the effectiveness of 125mg/50ml sodium thiosulfate (STS) solution to normal saline (0.9% sodium chloride) when injected intralesionally for the treatment of calcinosis cutis. Our specific aim is to assess the response of dystrophic and idiopathic calcinosis ...
What is the current status of trial NCT03639779?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2018-11-02. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03639779?
The interventions under investigation include: Saline Solution (OTHER), Sodium Thiosulfate (DRUG).
Who is sponsoring clinical trial NCT03639779?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.